Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Reports First Quarter 2016 Financial Results and Provides Corporate Update
10 mai 2016 06h30 HE | Dermira, Inc.
- Positive Topline Results for DRM01 Phase 2b Acne Trial Reported; Phase 3 Program Planning Underway - Announcement of Topline Results for DRM04 Phase 3 Hyperhidrosis Pivotal Trials Expected in...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Announces Positive Topline Phase 2b Clinical Trial Results for DRM01 in Patients with Facial Acne Vulgaris
10 mai 2016 06h00 HE | Dermira, Inc.
- Safety and Efficacy Data Confirm Results from Previous Phase 2a Trial - DRM01 Phase 3 Clinical Program Planning Underway - Management to Host Webcast and Conference Call Today at 5:30 a.m....
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Completes Patient Enrollment for First CIMZIA(R) (Certolizumab Pegol) Phase 3 Clinical Trial in Psoriasis Program
12 oct. 2015 16h21 HE | Dermira, Inc.
MENLO PARK, Calif., Oct. 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira_Logo_RGB_R4V2_M01.jpg
Dermira Presents Data From DRM01 Phase 2a Trial at European Academy of Dermatology and Venereology
07 oct. 2015 07h30 HE | Dermira, Inc.
MENLO PARK, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...